Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.95354 | 65 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.95924 | 66 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.76818 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.73097 | 63 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.84793 | 65 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.88086 | 64 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.04541 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.73139 | 62 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.50331 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.83088 | 64 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.8631 | 64 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.98258 | 66 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.92083 | 65 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.82778 | 64 |